Article info

Original research
Exploring the safety, effect on the tumor microenvironment, and efficacy of itacitinib in combination with epacadostat or parsaclisib in advanced solid tumors: a phase I study

Authors

  1. Correspondence to Dr Aung Naing; anaing{at}mdanderson.org
View Full Text

Citation

Naing A, Powderly JD, Nemunaitis JJ, et al
Exploring the safety, effect on the tumor microenvironment, and efficacy of itacitinib in combination with epacadostat or parsaclisib in advanced solid tumors: a phase I study

Publication history

  • Accepted February 8, 2022
  • First published March 14, 2022.
Online issue publication 
March 14, 2022
  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.